Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal

Drug-induced liver injury (DILI) with nintedanib has emerged as an adverse event of special interest in premarketing clinical trials. We characterized DILI with nintedanib in the real world and explored the underlying pharmacological basis. First, we assessed serious hepatic events reported to the F...

Full description

Saved in:
Bibliographic Details
Main Authors: Emanuel Raschi (Author), Michele Fusaroli (Author), Milo Gatti (Author), Paolo Caraceni (Author), Elisabetta Poluzzi (Author), Fabrizio De Ponti (Author)
Format: Book
Published: MDPI AG, 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available